Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
iBio, Inc. (IBIO) had Consolidated Net Income/Loss of $-5.16M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.20M |
|
$-5.16M |
|
-- |
|
$0.20M |
|
$5.40M |
|
$-5.20M |
|
$0.04M |
|
$-5.16M |
|
$-5.16M |
|
$-5.16M |
|
$-5.16M |
|
|
Consolidated Net Income/Loss |
$-5.16M |
$-5.16M |
|
$-5.20M |
|
$-4.91M |
|
10.50M |
|
10.50M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$9.72M |
|
$3.16M |
|
$13.46M |
|
$23.18M |
|
$6.11M |
|
-- |
|
$2.20M |
|
$8.30M |
|
$14.88M |
|
$8.03M |
|
$14.88M |
|
19.35M |
|
| Cash Flow Statement Financials | |
$-15.30M |
|
$0.74M |
|
$8.93M |
|
$14.43M |
|
$8.79M |
|
$-5.63M |
|
$1.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.59 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
100.00% |
|
-2599.00% |
|
-2599.00% |
|
-- |
|
-2581.50% |
|
-2581.50% |
|
$-15.32M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.90 |
|
47.25 |
|
-34.70% |
|
-64.28% |
|
-22.27% |
|
-34.70% |
|
$0.77 |
|
$-1.46 |
|
$-1.46 |
|